4-Pro-MET (4-propionyloxy-N-methyl-N-ethyltryptamin) er en syntetisk tryptaminforbindelse med sumformlen C15H20N2O2 og en molekylvægt på 274,364 g/mol. Som prodrug af 4-HO-MET (metocin) befinder stoffet sig midt i debatten om forskemikali. Hvad er den retlige status i Danmark, Skandinavien og EU -- per april 2026? Denne artikel viser, hvorfor 4-Pro-MET hverken falder under narkotikalovgivningen eller lovgivningen om nye psykoaktive stoffer. Og den forklarer den kemiske logik bag denne klassificering.

Ja – 4-Pro-MET er per april 2026 i Danmark hverken opført på liste A, B eller C i lov om euforiserende stoffer eller på listen over nye psykoaktive stoffer. Besiddelse, erhvervelse, salg: ingen narkotikaretlige begrænsninger. Denne vurdering støtter sig på en analyse af de gældende lovtekster og stofgruppedefinitioner.

I forskningsmiljøet anses 4-Pro-MET for at være en af de få tryptaminforbindelser, der er frit tilgængeligt til forskningsformål. Men afgrænsningen er subtil – den afhænger af et enkelt strukturelt detalje. Vi gennemgår det trin for trin.

Nøglebudskabet, hvis du vil være på den sikre side: Den retlige status er i øjeblikket klar. 4-Pro-MET er i Danmark ikke underlagt narkotikaretlig kontrol. Alligevel: Kontroller altid den aktuelle lovgivning inden enhver bestilling, da reguleringer ændrer sig. Vi opdaterer denne artikel ved hver lovendring og angiver datoen for den seneste kontrol.

The BtMG does not list 4-Pro-MET by name in any of its three schedules (Anlagen I�III). Germany's narcotics law relies on explicit compound listings, not structural group bans. As of April 2026, the BtMG Anlage I contains approximately 640 individually named substances. 4-Propionyloxy-N-methyl-N-ethyltryptamine isn't among them.

How the BtMG Schedules Work

Three categories divide the controlled substances: Anlage I (non-prescribable narcotics), Anlage II (marketable but prescription-only), and Anlage III (prescription narcotics). New entries are added through amendments proposed by the Federal Ministry of Health, typically after a risk assessment by the BfArM (Federal Institute for Drugs and Medical Devices). From initial evaluation to gazette publication, this process can take 12–24 months.

Several tryptamines are listed – psilocybin, psilocin, DMT, and 5-MeO-DMT among them – but the 4-substituted propionyloxy variants have not been individually scheduled. And here's the key distinction: 4-AcO-DMT was added to Anlage I in 2022, yet that was a substance-specific listing. It doesn't automatically extend to other 4-acyloxy tryptamines with different N-alkyl substitution patterns.

Could 4-Pro-MET Be Added to the BtMG?

In theory, yes. The BfArM monitors novel psychoactive compounds through the EU Early Warning System, which reported over 50 new synthetic compounds in 2025 alone. But scheduling typically follows evidence of widespread use or documented harm. Community survey data suggests 4-Pro-MET usage stays niche – estimated at fewer than 5,000 users across the DACH region – which likely lowers its scheduling priority.

The NpSG, enacted in November 2016, works differently. Instead of listing individual compounds, it defines entire structural groups. For tryptamines, the relevant definition is Substance Group 5.1 (Indol-3-alkylamines). It specifies an indole core structure and exhaustively lists the permitted substituents at positions 4–7 of the indole ring (the so-called Rn substituents).

Why 4-Pro-MET Falls Outside the NpSG

The Rn substituent list in Substance Group 5.1 reads: ?Hydrogen, fluorine, chlorine, bromine, iodine, alkyl (up to C4), alkyloxy (up to C10), benzyloxy, carboxamido, methoxy, trialkylsilyl, trifluoromethyl, trifluoromethoxy, acetoxy, hydroxy, and methylthio groups.? Only acetoxy (the acetic acid ester, C2) is listed – propionyloxy (the propionic acid ester, C3) is absent. Because 4-Pro-MET carries a propionyloxy group at position 4 of the indole ring, and this substituent isn't among the enumerated Rn options, the substance falls outside the definition. The 6th NpSG Amendment (published December 1, 2025; effective April 12, 2026) added trialkylsilyl, trifluoromethyl, and trifluoromethoxy to the list but did not add propionyloxy.

What the NpSG Actually Prohibits

The NpSG criminalizes trading, manufacturing for trade, or importing covered substances – but personal possession is not an offense under this law (unlike the BtMG). So even if 4-Pro-MET were reclassified in a future amendment, legal consequences would apply to commercial activity, not personal possession. One caveat: the Bundesgesundheitsministerium can close this gap at any time by adding propionyloxy or a broader ?alkanoyloxy? term to the Rn list.

Lovgivning ændrer sig. Punkt. Sundhedsmyndighederne kontrollerer regelmæssigt, om nye stoffer skal optages på listerne. Ændringer i lovgivningen kræver typisk 6–18 måneders forberedelsestid -- fra ekspertudvalgets anbefaling over udkastet til offentliggørelsen. Altså ingen ændringer hen over natten.

Mulige scenarier for 2026 og frem

Adskillige udviklinger kunne påvirke den retlige status.

• Tilføjelse til narkotikalisten: En navnlig optagelse af 4-Pro-MET er teoretisk mulig, men kræver en ekspertanbefaling. Lille markedsandel, ingen rapporter om sundhedshændelser -- kortsigtet usandsynligt. EMCDDA/EUDA har endnu ikke optaget 4-Pro-MET i sit tidlige varslingssystem (EU Early Warning System).
• Reform af stofgruppelovgivningen: En udvidelse af stofgruppedefinitionerne kunne fremover også inddrage tryptaminer uden oxo-sidekæde. Diskussioner herom kører på EU-plan siden 2023 inden for rammerne af EU's narkotikaforordning. Det ville fuldstændigt ændre den retlige situation for 4-Pro-MET -- men er endnu ikke besluttet.
• EU-bred harmonisering: EU-narkotikaforordningen (Regulation 2023/2127) kan på mellemlang sigt påvirke national regulering. EUDA overvåger løbende nye stoffer og giver anbefalinger til medlemsstaterne. Hidtil har EUDA ikke foretaget en risikovurdering af 4-Pro-MET.
• Blanket Ban-modeller: Nogle EU-stater (Irland, UK) anvender pauschalforbud. I de fleste lande anses dette for usandsynligt pga. retssikkerhedsmæssige betænkeligheder.

Vores råd: Hold dig opdateret. Vi opdaterer denne artikel ved enhver relevant ændring og angiver kontroldatoen. Abonner på vores nyhedsbrev for at blive informeret om lovendringer.

4-Pro-MET is legal in Germany right now. That could change. The regulatory environment around novel psychoactive substances moves, and several factors could trigger reclassification during 2026 or later.

EU-Level Early Warning System

The EMCDDA (now EUDA – European Union Drugs Agency since July 2024) monitors novel substances through its Early Warning System. If 4-Pro-MET gets formally notified and a risk assessment is triggered, EU member states may be prompted to act. In 2025, the EUDA issued risk assessments for 4 tryptamine-related compounds – none of which were 4-Pro-MET. On average, the gap from EUDA risk assessment to national scheduling runs about 18 months across EU member states.

German Legislative Calendar

Germany's BtMG amendment process (Betäubungsmittelrechts-Änderungsverordnung) typically runs 1–2 times per year. The most recent amendment (38th BtMÄndV) entered into force in October 2025 and did not include any 4-propionyloxy tryptamines. Next expected window: Q3/Q4 2026. NpSG structural group updates are a heavier lift – they require full Bundestag legislation, which is slower and politically harder to push through.

Signals to Watch

Scheduling may be approaching if you see: EUDA formal notification of 4-Pro-MET, BfArM public consultations mentioning propionyloxy tryptamines, seizure reports from German customs (Zoll), or increased media coverage. As of April 2026, none of these triggers have been activated for 4-Pro-MET.

Ordering 4-Pro-MET legally in Germany comes down to choosing a vendor that provides analytical verification and ships from within the EU.

Vendor Quality Indicators

A trustworthy supplier should include third-party lab analysis (Certificate of Analysis / CoA) with each batch, confirming identity and purity via HPLC and NMR. Vendors providing CoA documentation average above 98% product purity, compared to roughly 85–92% for unverified sources. Stick with EU-based shipping to avoid customs headaches – shipments from outside the EU face a roughly 15–20% seizure rate according to harm reduction community reports from 2025.

Payment and Privacy

Most vendors accept bank transfer (SEPA), cryptocurrency, and sometimes credit cards. Discreet packaging and GDPR compliance are baseline expectations for any legitimate EU-based research chemical supplier. According to a 2025 European research chemical market survey, approximately 73% of transactions in the DACH region are completed via bank transfer.